As such, interventions in either mothers or fathers may have favourable impacts on foetal SIRT1 regulation and the associated metabolic pathways, hence reducing the risk of developing obesity and metabolic disorders such as type 2 diabetes and non-alcoholic fatty liver disease. This evidence concerns the gene SIRT1 and metabolic disease.